HIMSS TV
Before deciding how and when to adopt AI, Nicolas Ostrowski of Future Processing advises businesses to have a technology roadmap, sound data practices and strong cybersecurity in place.
HIMSS24
Hospital pricing data can be difficult for consumers to understand. Cody Coonradt, Billy's CEO and founder, says the company's app puts this data into a user-friendly interface that patients can use to save money on care.
Aaron Blackmon and Joshua Mattson, DuploCloud account executives, discuss cybersecurity and how the company helps digital health and health tech companies with backend cloud infrastructure automation.
Sanofi head of organization capability and transformation, Felix Lee, discusses how the pharma giant leverages digital therapeutics company DarioHealth to complement its drug offerings and enhance patient care and self-management.
Meg Barron, managing director of engagement and outreach at Peterson Health Technology Institute, highlights how the organization independently evaluates digital health offerings and its recent report on digital musculoskeletal solutions.
Amos Adler, founder and president of MEMOTEXT, discusses how the company builds and commercializes digital engagement tools, its digital app for schizophrenia and psychosis patients, and Canadian vs. U.S. markets for digital therapeutics.
HIMSS24
Amid the trend of healthcare companies leveraging AI, Jerry Villacres, Manifold's VP of Sales, Cloud Solutions, cautions that they must first implement a sound data strategy to make the most out of those tools.
HIMSS24
Mark Polyak, president of global data management at IPSOS, says LLMs can "talk" to patients about administrative tasks like scheduling, but bias and model compatibility must be addressed before clinical deployments.
Harvard research associate Brian Spisak discusses how a "leadership-first, tech-last" approach can prevent organisations from deploying ticking time bombs.
Michael Pace, founder and president of PalmHealthCo, highlights how his company advises organizations, including pharma, in commercialization and go-to-market strategies for digital therapeutics - and his experience at Pear Therapeutics.